Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0IX7S
|
||||
Former ID |
DNC000917
|
||||
Drug Name |
MDL 100,453
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [534895] | ||
Structure |
Download2D MOL |
||||
Formula |
C5H10NO6P
|
||||
Canonical SMILES |
C(C(C(=O)O)N)C(=O)CP(=O)(O)O
|
||||
InChI |
1S/C5H10NO6P/c6-4(5(8)9)1-3(7)2-13(10,11)12/h4H,1-2,6H2,(H,8,9)(H2,10,11,12)/t4-/m1/s1
|
||||
InChIKey |
OLCWOBHEVRCMLO-SCSAIBSYSA-N
|
||||
CAS Number |
CAS 129938-34-7
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Glutamate [NMDA] receptor subunit epsilon 1 | Target Info | Antagonist | [534895] | |
KEGG Pathway | Ras signaling pathway | ||||
Rap1 signaling pathway | |||||
Calcium signaling pathway | |||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Circadian entrainment | |||||
Long-term potentiation | |||||
Glutamatergic synapse | |||||
Dopaminergic synapse | |||||
Alzheimer's disease | |||||
Amyotrophic lateral sclerosis (ALS) | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Nicotine addiction | |||||
Alcoholism | |||||
Systemic lupus erythematosus | |||||
Pathway Interaction Database | Reelin signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.